Characteristics and reasons associated with non-acceptance of selective serotonin reuptake inhibitor treatment

被引：0
|
作者：
van Geffen, Erica Cg [1 ]
van Hulten, Rolf [1 ]
Bouvy, Marcel L. [2 ]
Egberts, Antoine C. G. [1 ]
Heerdink, Eibert R. [1 ]
机构：
[1] Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands
[2] SIR Inst Pharm & Policy, Leiden, Netherlands
来源：
PHARMACY WORLD & SCIENCE | 2008年 / 30卷 / 05期
关键词：
antidepressants; discontinuation; nonadherence;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：658 / 658
页数：1
相关论文
共 50 条
  • [1] Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment
    van Geffen, Erica C. G.
    van Hulten, Rolf
    Bouvy, Marcel L.
    Egberts, Antoine C. G.
    Heerdink, Eibert R.
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (02) : 218 - 225
  • [2] Duloxetine, dual serotonin and norepinephrine reuptake inhibitor, versus paroxetine, selective serotonin reuptake inhibitor, in the treatment for premature ejaculation
    Ozcan, Levent
    Polat, Emre Can
    Otunctemur, Alper
    Ozbek, Emin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (02) : 283 - 287
  • [3] Retrobulbar hematoma associated with selective serotonin reuptake inhibitor: A case report
    Van Cann, Ellen M.
    Koole, Ronald
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 2009, 108 (04): : E1 - E2
  • [4] Association between selective serotonin and serotonin-noradrenaline reuptake inhibitor therapy and hematuria
    Sarier, Mehmet
    Demir, Meltem
    Emek, Mestan
    Ozgen, Ali
    Turgut, Hasan
    Ozdemir, Candan
    NORDIC JOURNAL OF PSYCHIATRY, 2023, 77 (01) : 31 - 35
  • [5] Selective serotonin reuptake inhibitor discontinuation syndrome: A review
    Tamam, L
    Ozpoyraz, N
    ADVANCES IN THERAPY, 2002, 19 (01) : 17 - 26
  • [6] Selective serotonin reuptake inhibitor discontinuation syndrome: A review
    Lut Tamam
    Nurgul Ozpoyraz
    Advances in Therapy, 2002, 19 : 17 - 26
  • [7] Selective serotonin reuptake inhibitor 'discontinuation syndrome' or withdrawal
    Massabki, Ivana
    Abi-Jaoude, Elia
    BRITISH JOURNAL OF PSYCHIATRY, 2021, 218 (03) : 168 - 171
  • [8] Economic Impact of Therapeutic Substitution of a Brand Selective Serotonin Reuptake Inhibitor with an Alternative Generic Selective Serotonin Reuptake Inhibitor in Patients with Major Depressive Disorder
    Wu, Eric Q.
    Yu, Andrew P.
    Lauzon, Veronique
    Ramakrishnan, Karthik
    Marynchenko, Maryna
    Ben-Hamadi, Rym
    Blum, Steven
    Erder, M. Haim
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (04) : 441 - 451
  • [9] Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline
    Thiels, C
    Linden, M
    Grieger, F
    Leonard, J
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (01) : 1 - 7
  • [10] A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache
    Bendtsen, L
    Jensen, R
    Olesen, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (03) : 285 - 290
12345